jump to content jump to footer

Leverage Advanced AI-Driven Nodule Detection and Analysis for Comprehensive Patient Care

Discover the power of streamlined AI-driven lung screening with contextflow ADVANCE Chest CT integrated into mint Lesion. With automated lung nodule detection and segmentation, contextflow highlights findings directly within the mint Lesion platform, where users can seamlessly review, customize or add findings.

mint Lesion supports the Lung-RADS 2022 guidelines, featuring built-in automated scoring to enhance accuracy and consistency in lung nodule evaluation. contextflow ADVANCE Chest CT extends its capabilities beyond nodules, assisting in the analysis of COPD and *coming soon* identifying calcifications in coronary vessels, equipping users with deeper insights for comprehensive care.

Explore how the innovative solution is going to be integrated into the cutting-edge deepcOS® AIR® ecosystem. Check out this brief video on Youtube to see it in action.

From PCWG3 to PCWG4: Evolving Standards in Prostate Cancer Clinical Trials

The Prostate Cancer Working Group 4 (PCWG4) updates and extends the recommendations of PCWG3 to reflect a patient-centric approach, the emergence of…

Read more
Mint Medical and mediaire strengthen the prostate cancer care pathway with AI-Powered MRI Solutions

Mint Medical, a Snke company, and mediaire announce a collaboration to advance AI‑powered MRI workflows through the interoperability of mint Lesion…

Read more
mint Lesion usage during a clinical trial read, featuring the TGRM export tool.
Bridging the Gap Between RECIST and Survival: Why the FDA’s Analysis of the g Value is a Game-Changer

For decades, oncology trials have relied on RECIST 1.1 to evaluate drug efficacy. However, these categorical "snapshot" evaluations do not always…

Read more
scroll-top